Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 411 Cranbrooke Avenue TORONTO ON M4M 1N4 |
Tel: | N/A |
Website: | N/A |
IR: | N/A |
Key People | ||
N/A |
Business Overview |
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company's operations comprise a single segment engaged in the medical marijuana business. The Company's hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient's mouth, with an onset of action between five and thirty minutes. |
Financial Overview |
For the nine months ended 28 February 2023, Canntab Therapeutics Ltd revenues decreased 87% to C$34K. Net loss decreased 15% to C$1.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Employee compensation and benefits decrease of 58% to C$326K (expense), Professional fees decrease of 75% to C$138K (expense). |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $1.34M as of Feb 28, 2023 |
Annual revenue (TTM): | $0.07M as of Feb 28, 2023 |
EBITDA (TTM): | -$1.59M as of Feb 28, 2023 |
Net annual income (TTM): | -$3.36M as of Feb 28, 2023 |
Free cash flow (TTM): | -$1.43M as of Feb 28, 2023 |
Net Debt Last Fiscal Year: | $1.88M as of Feb 28, 2023 |
Shares outstanding: | 38,909,159 as of Mar 7, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |